It is well known that oral contraceptive pills (OCP) induce, as a side effect, hyperreninemia with or without hypertension. (Woods, J. W., 1967 , Laragh, G. H. et al., 1967 It seemed worthwhile, therefore, to investigate if the same side effect will occur when sex hormone is given as substitutional therapy for the development of genitalia in such patients with primary hypogonadism as those with Turner's syndrome.
This paper deals with plasma renin activity (PRA) level and blood pressure when cyclic estrogen and progesterone administration (modified Kaufmann therapy) was instituted in 28 patients with gonadal dysgenesis and 13 patients with growth hormone and gonadotropin deficiencies (hypopituitarism).
Subjects and Methods
Thirty-eight patients with gonadal dysgenesis were diagnosed by chromosome analysis. The karyotype is described in Table 1 .
Sex hormone was given to 28 of the 38 patients, and the remaining 10 were studied without medication as control sub jects.
Twenty patients with idiopathic growth hormone and gonadotropin deficiencies (hypopituitarism) were diagnosed according to the following criteria. 1) no growth hormone (GH) response to insulin-induced hypoglycemia and arginine infusion; maximum level of GH is less than 5ng/ml. 2) bone age retardation ; bone age to chronological age ratio is less than 0.75. 3) growth velocity; less than 12cm/3 years. Modified Kaufmann therapy Estriol was given at a dose of 1 mg per day for 11 days, followed by combined substitution with mestranolol 0.05mg and progesterone (chlormaginon acetate) 2mg per day for 10 days. dysgenesis and hypopituitarism, respectively. There was no significant difference in the mean blood pressure before and during the therapy or in treated and non-treated patients. However, as described in Table 1 , systolic pressure exceeded 140mmHg in 3 patients with gonadal dysgenesis. (Cases No. 2, 25, 27) The therapy was discontinued in cases No. 2 and 25 and their blood pressures were 126/76mmHg and 118/72mmHg after 6 months, respectively.
In case No. 27, the dose of sex hormone was decreased to the initial dose and her blood pressure became 124/76mmHg after 3 months.
3) Serial change in PRA after the therapy was discontinued or the dose of estrogen was reduced in 4 patients.
In the first patient (Case No. 25), blood pressure was 196/124 mmHg when she was admitted to the hospital complaining of a high fever, headache and shoulder stiffness. PRA and aldosterone levels were 12.0ng/ ml/hr and 126pg/ml, respectively. Kaufmann therapy was discontinued on admission. Renal angiography revealed no abnormality and computer tomography of the kidney also revealed no laterality in size and density. Blood for measurement of PRA was obtained from both renal veins and PRA levels were 27.5 in the right and 24.8ng/ml/hr in the left sides, respectively. These data suggested no evidence of renovascular hypertension.
Angiotensin-converting-enzyme-inhibitor was given for one week. The change in PRA and blood pressure after this episode et al., 1969 , Skinner, S. L. et al., 1969 , Crane, M. G. et al., 1971 , Fisch, I. R. and Frank, J., 1977 , McAreavey, D. et al., 1983 . In Kaufmann therapy, higher doses of estrogen are usually used in order to produce sexual development than in contraceptive drugs. Furthermore, this therapy for patients with hypogonadism, is usually continued for long enough to develop genitalia to the adult stage and to prepare the person for normal sexual life after marriage.
In our study, the basal PRA level of non-treated patients with gonadal dysgenesis and hypopituitarism was defined as less than 7ng/ml/hr. This is higher than those of the normal range previously reported (Haber, et al., 1969; Ikeda, et al., 1981) . The reason for this difference is probably because the blood sample was obtained in the afternoon at the out-patient department following a one hr rest in the supine position. Though there was no statistically significant difference between the mean PRA level in non-treated and treated patients either with gonadal dysgenesis or with hypopituitarism, the PRA level exceeded 7ng/ml/hr in 9 patients with gonadal dysgenesis and in 1 patient with hypopituitarism.
Systolic blood pressure was over 140 mmHg in 3 patients with gonadal dysgenesis during Kaufmann therapy, and frequencies of hyperreninemia and hypertension were 23% and 7%, respectively.
The high frequency of the former is probably due to the high dose of estrogen given, since high PRA and hypertension disappeared within 6 months when the therapy was discontinued or the dose was decreased to half. The PRA level was related neither to the duration of therapy nor to the total amount of estrogen given.
Hypertension was noted only in gonadal dysgenesis, but these limited data do not give us any explanation for the difference in the frequency of hyperreninemia and hypertension in gonadal dysgenesis and hypopituitarism.
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